BIO-TECHNE Corp
Current role
TECH
Dr. Matthew McManus
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Matthew McManus
BIO-TECHNE Corp reported in an 8-K filed January 8, 2024 that Dr. Matthew McManus was appointed President – Diagnostics and Genomics Segment, effective January 8, 2024.
“On January 5, 2024, Bio-Techne Corporation (the "Company") announced the appointment of Dr. Matthew McManus, age 55, as President – Diagnostics and Genomics Segment ("President DGS") effective January 8, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
BIO-TECHNE Corp (TECH)
SEC 8-K
Current2024-01-08–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at BIO-TECHNE Corp
Other people whose current roles at this company are on record from its filings.
- Charles Kummeth CEO
- James T. Hippel CFO
- Kim Kelderman COO, Board Member
- Shane Bohnen General Counsel
- Alpna Seth Board Member
- Amy Herr Board Member
- Charles R. Kummeth Board Member
- Dr. Amy Herr Board Member
- Dr. Judith Klimovsky Board Member
- John L. Higgins Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.